Publications by authors named "Sarah Buhrow"

Claim this Profile
A
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies.
Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, Vera J Suman, Jill M Schimke, Sarah A Buhrow

Clin Cancer Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts.
Faizal Z Asumda, Nellie A Campbell, Mohamed A Hassan, Reza Fathi, Daniella F Vasquez Rico, Sarah A Buhrow

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia.
Aref Al-Kali, Ibrahim Aldoss, Pamela J Atherton, Carrie A Strand, Bijal Shah, Sarah A Buhrow

Cancer Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a liquid chromatography-mass spectrometry assay for quantification of Z- and E- isomers of endoxifen and its metabolites in plasma from women with estrogen receptor positive breast cancer.
Sarah A Buhrow, Emily J Koubek, Matthew P Goetz, Matthew M Ames, Joel M Reid

J Chromatogr B Analyt Technol Biomed Life Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioavailability and Pharmacokinetics of Endoxifen in Female Rats and Dogs: Evidence to Support the Use of Endoxifen to Overcome the Limitations of CYP2D6-Mediated Tamoxifen Metabolism.
Emily J Koubek, Sarah A Buhrow, Stephanie L Safgren, Lee Jia, Matthew P Goetz

Drug Metab Dispos· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of Z-Endoxifen in Patients With Advanced Solid Tumors.
Emily J Koubek, Andrew T Ralya, Thomas R Larson, Renee M McGovern, Sarah A Buhrow

J Clin Pharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reductive amination of α-Ketoglutarate in metabolite extracts results in glutamate overestimation.
Elizabeth K Wiese, Sadae Hitosugi, Sarah A Buhrow, Sharon T Loa, Annapoorna Sreedhar

J Chromatogr A· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer.
Swaathi Jayaraman, Xiaonan Hou, Mary J Kuffel, Vera J Suman, Tanya L Hoskin, Sarah A Buhrow

Breast Cancer Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Antibody-Targeted Chemotherapy for the Treatment of Melanoma.
Wendy K Nevala, Sarah A Buhrow, Daniel J Knauer, Joel M Reid, Elena A Atanasova

Cancer Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer.
Matthew P Goetz, Vera J Suman, Joel M Reid, Don W Northfelt, Michael A Mahr, Sarah A Buhrow

J Clin Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-Targeted Chemotherapy for the Treatment of Melanoma.
Wendy K Nevala, Sarah A Buhrow, Daniel J Knauer, Joel M Reid, Elena A Atanasova

Cancer Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Metabolism of Batracylin (NSC 320846) and N-acetylbatracylin (NSC 611001) Using Human, Dog, and Rat Preparations .
Joseph M Covey, Joel M Reid, Sarah A Buhrow, Mary Kuffel, Chad Walden

J Drug Metab Toxicol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Batracylin-induced Renal and Bladder Toxicity in Rats.
Myrtle Davis, Deborah I Bunin, Steven J Samuelsson, Kenneth P Altera, Robert J Kinders, Sarah A Buhrow

Toxicol Pathol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen.
Stephanie L Safgren, Vera J Suman, Matthew L Kosel, Judith A Gilbert, Sarah A Buhrow

Pharmacogenet Genomics· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of endoxifen and tamoxifen in female mice: implications for comparative in vivo activity studies.
Joel M Reid, Matthew P Goetz, Sarah A Buhrow, Chad Walden, Stephanie L Safgren

Cancer Chemother Pharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mouse pharmacokinetics and metabolism of the curcumin analog, 4-piperidinone,3,5-bis[(2-fluorophenyl)methylene]-acetate(3E,5E) (EF-24; NSC 716993).
Joel M Reid, Sarah A Buhrow, Judith A Gilbert, Lee Jia, Mamoru Shoji

Cancer Chemother Pharmacol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group.
Judith G Villablanca, Wendy B London, Arlene Naranjo, Patrick McGrady, Matthew M Ames, Sarah A Buhrow

Clin Cancer Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, pharmacodynamics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136 in rats.
Joel M Reid, Sarah A Buhrow, Mary J Kuffel, Lee Jia, Victoria J Spanswick

Cancer Chemother Pharmacol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.
Chitta Ranjan Patra, Resham Bhattacharya, Enfeng Wang, Aaron Katarya, Julie S Lau, Sarah A Buhrow

Cancer Res· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicology and pharmacokinetics of 1-methyl-d-tryptophan: absence of toxicity due to saturating absorption.
Lee Jia, Karen Schweikart, Joseph Tomaszewski, John G Page, Patricia E Noker, Sarah A Buhrow

Food Chem Toxicol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of mitochondrial respiration as a source of adaphostin-induced reactive oxygen species and cytotoxicity.
Son B Le, M Katie Hailer, Sarah Buhrow, Qi Wang, Karen Flatten

J Biol Chem· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LC-MS/MS assay and dog pharmacokinetics of the dimeric pyrrolobenzodiazepine SJG-136 (NSC 694501).
Sarah A Buhrow, Joel M Reid, Lee Jia, Renee M McGovern, Joseph M Covey

J Chromatogr B Analyt Technol Biomed Life Sci· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis